A quick online search shows supplement companies like Veracity and Codeage offering GLP-1 weight loss supplements of their own.
This triple-agonist approach explains why clinical trial participants achieved average weight loss of 24.2% at the 12mg dose over 48 weeks
ERR Estrogen-Related Receptor- (ERR), which belongs to the nuclear receptor subfamily, is a viable target for NAFLD and that the ERR agonist may serve as an intriguing pharmacological option for management of metabolic diseases ( via PGC1 (Singh et al., 2018)
Wipe that rubber stopper with alcohol too
In support of their role in weight management, GLP-1Rs are expressed in adipose tissue, where they regulate the proliferation of pre-adipocyte cells and lipid homeostasis (27)
Thats where prescription medicine for weight loss , like GLP-1s, comes in targeting appetite, cravings, and energy balance from the inside out